IRIS Accounts Production v24.3.0.553 11806226 director 1.3.23 29.2.24 29.2.24 false true false false true false Ordinary £1 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh118062262023-02-28118062262024-02-29118062262023-03-012024-02-29118062262022-02-28118062262022-03-012023-02-28118062262023-02-2811806226ns15:EnglandWales2023-03-012024-02-2911806226ns14:PoundSterling2023-03-012024-02-2911806226ns10:Director12023-03-012024-02-2911806226ns10:PrivateLimitedCompanyLtd2023-03-012024-02-2911806226ns10:SmallEntities2023-03-012024-02-2911806226ns10:AuditExempt-NoAccountantsReport2023-03-012024-02-2911806226ns10:SmallCompaniesRegimeForDirectorsReport2023-03-012024-02-2911806226ns10:SmallCompaniesRegimeForAccounts2023-03-012024-02-2911806226ns10:FullAccounts2023-03-012024-02-2911806226ns10:OrdinaryShareClass12023-03-012024-02-2911806226ns10:RegisteredOffice2023-03-012024-02-2911806226ns5:CurrentFinancialInstruments2024-02-2911806226ns5:CurrentFinancialInstruments2023-02-2811806226ns5:Non-currentFinancialInstruments2024-02-2911806226ns5:Non-currentFinancialInstruments2023-02-2811806226ns5:ShareCapital2024-02-2911806226ns5:ShareCapital2023-02-2811806226ns5:FurtherSpecificReserve3ComponentTotalEquity2024-02-2911806226ns5:FurtherSpecificReserve3ComponentTotalEquity2023-02-2811806226ns5:RetainedEarningsAccumulatedLosses2024-02-2911806226ns5:RetainedEarningsAccumulatedLosses2023-02-2811806226ns5:PlantMachinery2023-03-012024-02-2911806226ns5:PlantMachinery2023-02-2811806226ns5:PlantMachinery2024-02-2911806226ns5:PlantMachinery2023-02-2811806226ns5:CostValuation2023-02-2811806226ns5:AdditionsToInvestments2024-02-2911806226ns5:DisposalsRepaymentsInvestments2024-02-2911806226ns5:RevaluationsIncreaseDecreaseInInvestments2024-02-2911806226ns5:CostValuation2024-02-2911806226ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-02-2911806226ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-02-2811806226ns10:OrdinaryShareClass12024-02-29
REGISTERED NUMBER: 11806226 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 29 FEBRUARY 2024

FOR

NOTTINGHAM GYNAECOLOGY LTD

NOTTINGHAM GYNAECOLOGY LTD (REGISTERED NUMBER: 11806226)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 29 FEBRUARY 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


NOTTINGHAM GYNAECOLOGY LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 29 FEBRUARY 2024







Director: D Nunns





Registered office: 10 Stadium Business Court
Millennium Way
Pride Park
Derby
Derbyshire
DE24 8HP





Registered number: 11806226 (England and Wales)





Accountants: Haines Watts (East Midlands) Ltd
10 Stadium Business Court
Millennium Way
Pride Park
Derby
Derbyshire
DE24 8HP

NOTTINGHAM GYNAECOLOGY LTD (REGISTERED NUMBER: 11806226)

BALANCE SHEET
29 FEBRUARY 2024

2024 2023
Notes £ £
Fixed assets
Tangible assets 4 35,213 45,217
Investments 5 52,909 20,600
88,122 65,817

Current assets
Debtors 6 52,753 128,062
Cash at bank 70,348 118,642
123,101 246,704
Creditors
Amounts falling due within one year 7 (59,098 ) (46,163 )
Net current assets 64,003 200,541
Total assets less current liabilities 152,125 266,358

Creditors
Amounts falling due after more than one
year

8

-

(43,549

)
Net assets 152,125 222,809

Capital and reserves
Called up share capital 10 100 100
Fair value reserve 11 2,909 -
Retained earnings 149,116 222,709
Shareholders' funds 152,125 222,809

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 29 February 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 29 February 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 21 October 2024 and were signed by:




D Nunns - Director


NOTTINGHAM GYNAECOLOGY LTD (REGISTERED NUMBER: 11806226)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 29 FEBRUARY 2024

1. STATUTORY INFORMATION

Nottingham Gynaecology Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

NOTTINGHAM GYNAECOLOGY LTD (REGISTERED NUMBER: 11806226)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 29 FEBRUARY 2024

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£
Cost
At 1 March 2023 80,889
Additions 1,734
At 29 February 2024 82,623
Depreciation
At 1 March 2023 35,672
Charge for year 11,738
At 29 February 2024 47,410
Net book value
At 29 February 2024 35,213
At 28 February 2023 45,217

5. FIXED ASSET INVESTMENTS
Other
investments
£
Cost or valuation
At 1 March 2023 20,600
Additions 30,000
Disposals (600 )
Revaluations 2,909
At 29 February 2024 52,909
Net book value
At 29 February 2024 52,909
At 28 February 2023 20,600

Cost or valuation at 29 February 2024 is represented by:

Other
investments
£
Valuation in 2024 52,909

If fixed asset investments had not been revalued they would have been included at the following historical cost:

2024 2023
£ £
Cost 50,000 -

Fixed asset investments were valued on an open market basis on 29 February 2024 by Novia and Meteor investments .

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£ £
Trade debtors 30,305 36,976
Other debtors 22,448 91,086
52,753 128,062

NOTTINGHAM GYNAECOLOGY LTD (REGISTERED NUMBER: 11806226)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 29 FEBRUARY 2024

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£ £
Hire purchase contracts 43,549 6,786
Taxation and social security 13,574 37,522
Other creditors 1,975 1,855
59,098 46,163

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2024 2023
£ £
Hire purchase contracts - 43,549

9. SECURED DEBTS

The following secured debts are included within creditors:

2024 2023
£ £
Hire purchase contracts 43,549 50,335

Amounts owed under Hire Purchase contracts are secured against the asset to which they relate.

10. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £ £
100 Ordinary £1 £1 100 100

11. RESERVES
Fair value
reserve
£
Investment fair value uplift 3,591
reserve (682 )

At 29 February 2024 2,909

12. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 29 February 2024 and 28 February 2023:

2024 2023
£ £
**UNKNOWN DIRECTOR 1**
Balance outstanding at start of year 89,228 (122 )
Amounts advanced 21,607 90,000
Amounts repaid (90,312 ) (650 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 20,523 89,228

The overdrawn Director Loan Account was cleared in full after the year end, but before the date of these Reports.